Who
John Kiely
Director
Company insider
Files Form 4 as: Director, Amneal Pharmaceuticals; Director, Zovio.
In numbers
- Trades disclosed
- 51
- Buys
- 2
- Sells
- 4
- Bought
- $87K
- Sold
- $2.6M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 31 Aug 2019
- Last trade
- 13 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 14 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $882K50,000 at $17.64 | filing |
| 13 Aug 2026filed 14 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code G | —10,000 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $882K50,000 at $17.64 | filing |
| 13 Aug 2026filed 14 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code G | —10,000 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 27 Aug 2025filed 28 Aug 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $295K32,000 at $9.23 | filing |
| 12 May 2025filed 13 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $380K50,000 at $7.59 | filing |
| 6 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,819 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —40,258 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —40,258 | filing |
| 22 Nov 2024filed 26 Nov 2024 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —28,506 at $0.00 | filing |
| 22 Nov 2024filed 26 Nov 2024 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $136K28,506 at $4.76 | filing |
| 22 Nov 2024filed 26 Nov 2024 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $143K17,058 at $8.38 | filing |
| 10 May 2024filed 14 May 2024 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —76,453 at $0.00 | filing |
| 10 May 2024filed 14 May 2024 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —76,453 | filing |
News
Head to Head Contrast: Amneal Pharmaceuticals (NASDAQ:AMRX) & NRx Pharmaceuticals (NASDAQ:NRXP)AMRX · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name John Kiely; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.